Allogene Therapeutics, Inc. (ALLO) quarterly income statement — complete revenue, gross profit & net income history
Allogene Therapeutics, Inc. (ALLO) annual income statement — 9-year revenue, gross profit & net income history
| Metric | Q2'26 | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 | Q3'21 |
|---|
| Sales/Revenue | 4.64M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 22K | -44K | 22K | 22K | 30K | 47K | 49K | 86K | 61K | 51K | 49K |
| Revenue Growth % | - | - | - | - | - | -100% | 100% | -100% | -100% | -26.67% | -193.62% | -55.1% | -74.42% | -50.82% | -7.84% | 0% | 95.45% | -99.84% | - | - |
| Cost of Goods Sold | 0 | 2.87M | 3.06M | 31.16M | 40.16M | 3.1M | 3.23M | 44.71M | 50.35M | 3.56M | 0 | 3.57M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| COGS % of Revenue | - | - | - | - | - | - | - | - | - | 16159.09% | - | 16236.36% | - | - | - | - | - | - | - | - |
| Gross Profit | 4.64M | -2.87M | -3.06M | -31.16M | -40.16M | -3.1M | -3.23M | -44.71M | -50.35M | -3.53M | -44K | -3.55M | 22K | 30K | 47K | 49K | 86K | 61K | 51K | 49K |
| Gross Margin % | 100% | - | - | - | - | - | - | - | - | -16059.09% | 100% | -16136.36% | 100% | 100% | 100% | 100% | 100% | 100% | 100% | 100% |
| Gross Profit Growth % | 111.55% | 7.42% | 5.44% | 30.3% | 20.25% | 12.28% | -7247.73% | -1159.52% | -228986.36% | -11876.67% | -193.62% | -7344.9% | -74.42% | -50.82% | -7.84% | 0% | 95.45% | -99.84% | - | - |
| Operating Expenses | 51.56M | 43.22M | 39.35M | 13.74M | 16.66M | 62.09M | 57.26M | 27.06M | 21.08M | 65.97M | 85.13M | 59.45M | 80.56M | 99.12M | 96.42M | 82.54M | 76.68M | 80.05M | 73.94M | 77.72M |
| OpEx % of Revenue | 1111.21% | - | - | - | - | - | - | - | - | 299868.18% | -193477.27% | 270209.09% | 366190.91% | 330406.67% | 205151.06% | 168444.9% | 89162.79% | 131234.43% | 144988.24% | 158610.2% |
| Selling, General & Admin | 20.84M | 14.09M | 13.77M | 13.74M | 14.28M | 14.99M | 15.52M | 16.33M | 16.09M | 17.27M | 17.22M | 17.04M | 18.52M | 18.88M | 21M | 18.9M | 19.51M | 19.9M | 19.96M | 19M |
| SG&A % of Revenue | 449.12% | - | - | - | - | - | - | - | - | 78486.36% | -39145.45% | 77459.09% | 84200% | 62946.67% | 44685.11% | 38565.31% | 22684.88% | 32618.03% | 39139.22% | 38773.47% |
| Research & Development | 30.72M | 29.13M | 28.63M | 31.16M | 40.16M | 50.2M | 44.97M | 44.71M | 50.35M | 52.26M | 54.66M | 45.98M | 62.04M | 80.24M | 75.42M | 63.64M | 57.17M | 60.16M | 53.98M | 58.72M |
| R&D % of Revenue | 662.09% | - | - | - | - | - | - | - | - | 237540.91% | -124229.55% | 208986.36% | 281990.91% | 267460% | 160465.96% | 129879.59% | 66477.91% | 98616.39% | 105849.02% | 119836.73% |
| Other Operating Expenses | 0 | 0 | -1000K | -1000K | -1000K | -1000K | -1000K | -1000K | -1000K | -1000K | 1000K | -1000K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -46.92M | -46.09M | -42.4M | -44.9M | -56.82M | -65.19M | -60.49M | -71.77M | -71.43M | -69.5M | -85.17M | -63M | -80.54M | -99.09M | -96.37M | -82.49M | -76.59M | -79.99M | -73.89M | -77.67M |
| Operating Margin % | -1011.21% | - | - | - | - | - | - | - | - | -315927.27% | 193577.27% | -286345.45% | -366090.91% | -330306.67% | -205051.06% | -168344.9% | -89062.79% | -131134.43% | -144888.24% | -158510.2% |
| Operating Income Growth % | 17.42% | 29.3% | 29.9% | 37.44% | 20.46% | 6.21% | 28.98% | -13.93% | 11.31% | 29.86% | 11.62% | 23.63% | -5.15% | -23.88% | -30.42% | -6.2% | -7.83% | -140.93% | -6.53% | -14.15% |
| EBITDA | -44.27M | -43.22M | -39.35M | -41.8M | -53.71M | -62.09M | -57.26M | -68.57M | -67.79M | -65.95M | -81.7M | -59.42M | -76.9M | -95.58M | -93.31M | -78.63M | -72.92M | -76.3M | -69.65M | -75.34M |
| EBITDA Margin % | -954.2% | - | - | - | - | - | - | - | - | -299768.18% | 185675% | -270109.09% | -349531.82% | -318616.67% | -198523.4% | -160467.35% | -84789.53% | -125081.97% | -136570.59% | -153755.1% |
| EBITDA Growth % | 17.57% | 30.39% | 31.28% | 39.03% | 20.76% | 5.85% | 29.92% | -15.39% | 11.85% | 31% | 12.44% | 24.42% | -5.46% | -25.28% | -33.96% | -4.37% | -5.58% | -143.9% | -3.16% | -13.76% |
| D&A (Non-Cash Add-back) | 2.65M | 2.87M | 3.06M | 3.1M | 3.11M | 3.1M | 3.23M | 3.21M | 3.64M | 3.56M | 3.48M | 3.57M | 3.64M | 3.51M | 3.07M | 3.86M | 3.67M | 3.69M | 4.24M | 2.33M |
| EBIT | -42.33M | -42.31M | -38.5M | -41.06M | -50.67M | -59.58M | -59.41M | -66.19M | -66.36M | -65M | -71.93M | -62.29M | -80.54M | -99.09M | -96.37M | -82.49M | -76.59M | -79.99M | -73.89M | -77.67M |
| Net Interest Income | 4.3M | 3.27M | 3.35M | 3.58M | 5.92M | 5.37M | 2.95M | 6.61M | 4.99M | 5.43M | 6.26M | 6.21M | 3.78M | 2.06M | 2.76M | 1M | 315K | 492K | 186K | 393K |
| Interest Income | 4.65M | 3.57M | 3.66M | 3.93M | 6.19M | 5.52M | 3.03M | 6.71M | 4.99M | 5.43M | 6.26M | 6.21M | 3.78M | 2.06M | 2.76M | 1M | 315K | 492K | 186K | 393K |
| Interest Expense | 343K | 300K | 313K | 344K | 268K | 150K | 81K | 100K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Income/Expense | 4.24M | 3.48M | 3.59M | 3.5M | 5.88M | 5.46M | 994K | 5.48M | 5.07M | 4.5M | -4.08M | 709K | 1.31M | -876K | 1.53M | -659K | 1.81M | 142K | -975K | -516K |
| Pretax Income | -42.68M | -42.61M | -38.81M | -41.4M | -50.94M | -59.73M | -59.5M | -66.29M | -66.36M | -65M | -89.26M | -62.29M | -79.23M | -99.97M | -94.85M | -83.15M | -74.79M | -79.85M | -74.87M | -78.19M |
| Pretax Margin % | -919.76% | - | - | - | - | - | - | - | - | -295454.55% | 202856.82% | -283122.73% | -360145.45% | -333226.67% | -201802.13% | -169689.8% | -86961.63% | -130901.64% | -146800% | -159563.27% |
| Income Tax | 0 | 0 | 0 | 0 | 0 | 0 | 443K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Effective Tax Rate % | 0% | 0% | 0% | 0% | 0% | 0% | -0.74% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Net Income | -42.68M | -42.61M | -38.81M | -41.4M | -50.94M | -59.73M | -59.94M | -66.29M | -66.36M | -65M | -89.26M | -62.29M | -79.23M | -99.97M | -94.85M | -83.15M | -74.79M | -79.85M | -74.87M | -78.19M |
| Net Margin % | -919.76% | - | - | - | - | - | - | - | - | -295454.55% | 202856.82% | -283122.73% | -360145.45% | -333226.67% | -201802.13% | -169689.8% | -86961.63% | -130901.64% | -146800% | -159563.27% |
| Net Income Growth % | 16.23% | 28.67% | 35.25% | 37.55% | 23.23% | 8.1% | 32.85% | -6.43% | 16.25% | 34.98% | 5.89% | 25.09% | -5.94% | -25.19% | -26.69% | -6.35% | -5.43% | -141.86% | -9.18% | -18.11% |
| Net Income (Continuing) | -42.68M | -42.61M | -38.81M | -41.4M | -50.94M | -59.73M | -59.94M | -66.29M | -66.36M | -65M | -89.26M | -62.29M | -79.23M | -99.97M | -94.85M | -83.15M | -74.79M | -79.85M | -74.87M | -78.19M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | -0.13 | -0.18 | -0.17 | -0.19 | -0.23 | -0.28 | -0.28 | -0.32 | -0.35 | -0.38 | -0.51 | -0.37 | -0.54 | -0.68 | -0.66 | -0.58 | -0.52 | -0.56 | -0.54 | -0.57 |
| EPS Growth % | 43.48% | 35.71% | 39.29% | 40.63% | 34.29% | 26.32% | 45.1% | 13.51% | 35.19% | 44.12% | 22.73% | 36.21% | -3.85% | -21.43% | -22.22% | -1.75% | 1.89% | -124% | -1.89% | -9.62% |
| EPS (Basic) | -0.13 | -0.18 | -0.17 | -0.19 | -0.23 | -0.28 | -0.28 | -0.32 | -0.35 | -0.38 | -0.51 | -0.37 | -0.54 | -0.68 | -0.66 | -0.58 | -0.52 | -0.56 | -0.54 | -0.57 |
| Diluted Shares Outstanding | 328.93M | 240.29M | 220.62M | 222.04M | 218.93M | 215.36M | 210.57M | 209.19M | 190.03M | 169.13M | 168.34M | 167.65M | 146.8M | 144.56M | 144.15M | 143.66M | 143.38M | 141.36M | 139.17M | 137.03M |
| Basic Shares Outstanding | 328.93M | 240.29M | 220.62M | 222.04M | 218.93M | 215.36M | 210.57M | 209.19M | 190.03M | 169.13M | 168.34M | 167.65M | 146.8M | 144.56M | 144.15M | 143.66M | 143.38M | 141.36M | 139.17M | 137.03M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |